This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
875 posters, 25 topics, 3,440 authors, 1,061 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
March 25-28, 2026 | Tampa, FL, USA

P572
Foregut
Revisional Robotic-Assisted Surgery for Median Arcuate Ligament Syndrome: Is There a Role?
Gabriela V Lozano, BS; Nevyn A Santillan, BS; Elliot I Shiwota; Steve Chen, MD; Daniel Shouhed, MD
Providence Saint John's Health Center
INTRODUCTION
Surgical treatment for Median Arcuate Ligament Syndrome (MALS) has been reported to have a failure-to-treat rate of 28%1. Optimal indications for a repeat intervention and postoperative outcomes after revisional surgery have not been well documented. We evaluate the safety and efficacy of revisional surgery for MALS through a robotic-assisted approach by a single surgeon.
METHODS
STUDY DESIGN
• Retrospective chart review
• Patients who underwent revisional surgery for MALS
• Duration: November 2016 to July 2025
• n = 10
PATIENT SELECTION
• Patients were diagnosed with recurrent MALS based on:
Correlating symptoms, Objective evidence of celiac artery (CA) compression, Celiac ganglion nerve block (CGNB)
• All patients underwent a complete gastrointestinal (GI) workup
• Consideration was also given to the primary surgeon
• Patients were offered revisional surgery after meeting diagnostic criteria
RESULTS
• 10 patients underwent robotic revisional median arcuate ligament release and celiac ganglion and nerve plexus resection.
• 2 patients underwent primary operation by this surgeon
• Average patient age: 32.6 years
• 70% female
• Mean length of symptom duration: 14.7 months
CONCLUSION
• Favorable outcomes can be achieved in carefully selected patients.
• We have found that the following symptoms may be predictors of surgical success in the setting of a successful response to a CGNB:
• Postprandial epigastric pain
• Pain with all foods and liquids
• Worsened pain with large volumes
• Rapid and unexplained weight loss
• We have also found that patients in this population often present with an array of comorbidities, which can make diagnosis and treatment more challenging2-4.
• In this series:
• 90% achievedlong-term symptomatic relief postoperatively
• 40% achieved complete relief of chronic abdominal pain
• Only 1 patient (10%) experienced recurrence
• All patients underwent celiac ganglion and nerve plexus resection,indicating there may be an underappreciated neurogenic rather than vascular component to MALS.
• Based on this series, there is a 10% chance of major bleeding.
• Surgeons considering performing revisional MALS surgery should be well prepared for the possibility of significant vascular injury.